Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcranial Photobiomodulation Therapy for the Treatment of Autistic Traits in Children and Adolescents With Attention Deficit Hyperactivity Disorder

NCT04569058 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04569058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04569058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcranial Photobiomodulation Therapy for the Treatment of Autistic Traits in Children and Adolescents With Attention Deficit Hyperactivity Disorder
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 14, 2021
Completion date
October 31, 2024
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder, autism